257 related articles for article (PubMed ID: 2369009)
1. [B-lymphocyte hyperreactivity and differentiation factors of T-lymphocytes in systemic lupus erythematosus].
Humbert M; Galanaud P
Ann Med Interne (Paris); 1990; 141(3):213-6. PubMed ID: 2369009
[TBL] [Abstract][Full Text] [Related]
2. Effect of interferon-gamma on B lymphocytes of patients with systemic lupus erythematosus.
Funauchi M; Sugishima H; Minoda M; Horiuchi A
J Rheumatol; 1991 Mar; 18(3):368-72. PubMed ID: 1906936
[TBL] [Abstract][Full Text] [Related]
3. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
4. B-cell proliferation and differentiation in systemic lupus erythematosus and mixed connective tissue disease.
Kallenberg CG; van Dissel-Emiliani F; Huitema MG; Limburg PC; The TH
J Clin Lab Immunol; 1988 Jun; 26(2):55-61. PubMed ID: 3264025
[TBL] [Abstract][Full Text] [Related]
5. [Role of T lymphocytes in systemic lupus erythematosus].
Zubler RH; Miescher PA
Ann Med Interne (Paris); 1990; 141(3):208-12. PubMed ID: 2195945
[TBL] [Abstract][Full Text] [Related]
6. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
[TBL] [Abstract][Full Text] [Related]
7. Genetic and molecular genetic studies of murine and human lupus.
Steinberg AD; Klinman DM; Kastner DL; Seldin MF; Gause WC; Scribner CL; Britten JL; Siegel JN; Mountz JD
J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():166-76. PubMed ID: 3497269
[TBL] [Abstract][Full Text] [Related]
8. Regulators of B-cell activity in SLE: a better target for treatment than B-cell depletion?
Dolff S; Abdulahad WH; Bijl M; Kallenberg CG
Lupus; 2009 Jun; 18(7):575-80. PubMed ID: 19433456
[TBL] [Abstract][Full Text] [Related]
9. Responses of B cells from autoimmune mice to IL-5.
Umland SP; Go NF; Cupp JE; Howard M
J Immunol; 1989 Mar; 142(5):1528-35. PubMed ID: 2783944
[TBL] [Abstract][Full Text] [Related]
10. Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB x NZW)F1 and MRL/MpJ-lpr/lpr mice.
Merino R; Iwamoto M; Fossati L; Izui S
J Immunol; 1993 Dec; 151(11):6509-16. PubMed ID: 7902378
[TBL] [Abstract][Full Text] [Related]
11. Activation and immunoregulation of human B lymphocyte function: implications in normal and disease states.
Fauci AS
Monogr Allergy; 1983; 18():96-105. PubMed ID: 6358871
[No Abstract] [Full Text] [Related]
12. B cell apoptosis accelerates the onset of murine lupus.
Trébéden-Nègre H; Weill B; Fournier C; Batteux F
Eur J Immunol; 2003 Jun; 33(6):1603-12. PubMed ID: 12778478
[TBL] [Abstract][Full Text] [Related]
13. Evidence for polyclonal T cell activation in murine models of systemic lupus erythematosus.
Rozzo SJ; Drake CG; Chiang BL; Gershwin ME; Kotzin BL
J Immunol; 1994 Aug; 153(3):1340-51. PubMed ID: 7913114
[TBL] [Abstract][Full Text] [Related]
14. Expression and function of inducible co-stimulator in patients with systemic lupus erythematosus: possible involvement in excessive interferon-gamma and anti-double-stranded DNA antibody production.
Kawamoto M; Harigai M; Hara M; Kawaguchi Y; Tezuka K; Tanaka M; Sugiura T; Katsumata Y; Fukasawa C; Ichida H; Higami S; Kamatani N
Arthritis Res Ther; 2006; 8(3):R62. PubMed ID: 16563187
[TBL] [Abstract][Full Text] [Related]
15. Anti-nucleosome antibodies and T-cell response in systemic lupus erythematosus.
Fournel S; Muller S
Ann Med Interne (Paris); 2002 Dec; 153(8):513-9. PubMed ID: 12610425
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of nasal tolerance in lupus prone mice is T-cell anergy induced by immature B cells that lack B7 expression.
Wu HY; Monsonego A; Weiner HL
J Autoimmun; 2006 Mar; 26(2):116-26. PubMed ID: 16426816
[TBL] [Abstract][Full Text] [Related]
17. Studies of immune abnormalities in systemic lupus erythematosus.
Steinberg AD; Smith HR; Laskin CA; Steinberg BJ; Smolen JS
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):101-10. PubMed ID: 6213146
[TBL] [Abstract][Full Text] [Related]
18. Dissociation of severe lupus-like disease from polyclonal B cell activation and IL 2 deficiency in C3H-lpr/lpr mice.
Davidson WF; Roths JB; Holmes KL; Rudikoff E; Morse HC
J Immunol; 1984 Aug; 133(2):1048-56. PubMed ID: 6610701
[TBL] [Abstract][Full Text] [Related]
19. Stimulating and differentiation factors for human B lymphocytes in systemic lupus erythematosus.
Martinez-Cordero E; Alcocer-Varela J; Alarcon-Segovia D
Clin Exp Immunol; 1986 Sep; 65(3):598-604. PubMed ID: 3490941
[TBL] [Abstract][Full Text] [Related]
20. The potential role of immunoregulatory disturbance in the pathogenesis of systemic lupus erythematosus.
Bell DA
J Rheumatol; 1981; 8(2):340-4. PubMed ID: 6971937
[No Abstract] [Full Text] [Related]
[Next] [New Search]
